Skip to content

Montelukast

Two montelukast products sit on this shelf: Singulair, spanning 4 mg to 10 mg, and Montair at 10 mg. Both are tablets listed for Asthma, Allergic Rhinitis and exercise-induced bronchoconstriction.

Singulair

Asthma, Allergic Rhinitis

4mg · 5mg · 10mg

Montelukast tablets for asthma and allergic rhinitis. They block leukotrienes, so they prevent symptoms rather than stop an attack once it starts.

From$1.60/ tabletView

Montair

Asthma, Allergic Rhinitis

10mg

Montelukast tablets for asthma and allergic rhinitis. It blocks leukotrienes, the chemicals that set off airway swelling.

From$2.40/ tabletView

Key points

  • Montelukast carries a boxed warning for serious neuropsychiatric events: agitation, aggression, depression, sleep disturbance and suicidal thoughts have all been reported. The label advises stopping the medicine and contacting a healthcare provider if these occur.
  • Montelukast is a leukotriene receptor antagonist. It blocks inflammatory chemicals called leukotrienes that narrow the airways, increase mucus and draw immune cells into lung tissue.
  • Singulair is the original brand from Merck; Montair is Cipla’s generic version. Both contain montelukast sodium and share the same indications.

Brands and forms on this shelf

Singulair is available at 4 mg, 5 mg and 10 mg tablets; Montair is listed at 10 mg only. Singulair is marketed by Merck as the original brand; Montair is Cipla’s generic version of the same active ingredient. Both products sit in the Respiratory Health category.

Further reading